Evidence map›Paper›PMID 40987604›Full record

ArticleBMJ evidence-based medicine2026

Alcohol use and risk of dementia in diverse populations: evidence from cohort, case-control and Mendelian randomisation approaches.

Anya Topiwala, Daniel F Levey, Hang Zhou, Joseph D Deak, Keyrun Adhikari, Klaus P Ebmeier, Steven Bell, Stephen Burgess, Thomas E Nichols, Michael Gaziano and 2 more

Abstract read
In one paragraph

Article in BMJ evidence-based medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Overcoming dietary dogmas.Nature metabolism · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anya TopiwalaNuffield Department of Population Health, University of Oxford, Oxford, UK anya.topiwala@bdi.ox.ac.uk.ORCID 0000-0002-8408-0372
Daniel F LeveyDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Hang ZhouDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Joseph D DeakDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Keyrun AdhikariDepartment of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA.
Klaus P EbmeierDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID 0000-0002-5190-7038
Steven BellDepartment of Oncology & Cancer Reserach UK Cambridge Centre, University of Cambridge, Cambridge, UK.
Stephen BurgessMRC Biostatistics Unit & Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5365-8760
Thomas E NicholsDepartment of Psychiatry, University of Oxford, Oxford, UK.ORCID 0000-0002-4516-5103
Michael GazianoDepartment of Medicine, Harvard University, Cambridge, Massachusetts, USA.
Murray SteinDepartment of Psychiatry and School of Public Health, University of California, La Jolla, California, USA.
Joel GelernterVeterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.

Funding

BLRD VA I01 BX006482CSRD VA I01 CX001849Department of Health NIHR203312Medical Research Council MC_UU_00002/7Wellcome Trust 216462Wellcome Trust 225790
6 · The paper itself

Abstract

objectivesTo investigate the relationship between alcohol consumption and dementia.

designProspective cohort and case-control analyses combined with linear and non-linear Mendelian randomisation.

settingTwo large-scale population-based cohorts: the US Million Veteran Programme and the UK Biobank. Genetic analyses used summary statistics from genome-wide association studies (GWAS).

participants559 559 adults aged 56-72 years at baseline were included in observational analyses (mean follow-up: 4 years in the US cohort; 12 years in the UK cohort). Genetic analyses used summary data from multiple large GWAS consortia (2.4 million participants).

main outcome measuresIncident all-cause dementia, determined through health record linkage, and genetic proxies.

resultsDuring follow-up, 14 540 participants developed dementia and 48 034 died. Observational phenotype-only analyses revealed U-shaped associations between alcohol and dementia risk: higher risk was observed among non-drinkers, heavy drinkers (>40 drinks per week; HR 1.41, 95% CI 1.15 to 1.74), and those with alcohol use disorder (AUD) (HR 1.51, 95% CI 1.42 to 1.60) compared with light drinkers. In contrast, Mendelian randomisation genetic analysis identified a monotonic increase in dementia risk with greater alcohol consumption. A 1 SD increase in log-transformed drinks per week was associated with a 15% dementia increase (inverse-variance weighted (IVW) OR 1.15, 95% CI 1.03 to 1.27). A twofold increase in AUD prevalence was associated with a 16% increase in dementia risk (IVW OR 1.16, 95% CI 1.03 to 1.30). Alcohol intake increased dementia, but individuals who developed dementia also experienced a decline in alcohol intake over time, suggesting reverse causation-where early cognitive decline leads to reduced alcohol consumption-underlies the supposed protective alcohol effects in observational studies.

conclusionsThese findings provide evidence for a relationship between all types of alcohol use and increased dementia risk. While correlational observational data suggested a protective effect of light drinking, this could be in part attributable to reduced drinking seen in early dementia; genetic analyses did not support any protective effect, suggesting that any level of alcohol consumption may contribute to dementia risk. Public health strategies that reduce the prevalence of alcohol use disorder could potentially lower the incidence of dementia by up to 16%.

Indexed as

Alcohol DrinkingDementiaAgedAlcoholismCase-Control StudiesFemaleGenome-Wide Association StudyHumansMaleMendelian Randomization AnalysisMiddle AgedProspective StudiesRisk FactorsUnited KingdomUnited StatesAddiction MedicineDementiaNeurodegenerative DiseasesPUBLIC HEALTH

Identifiers

PMID40987604
PMCPMC7618643

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.